Association of factor expression levels with annual bleeding rate in people with haemophilia B

INTRODUCTION: Gene therapy clinical trials measure steady‐state clotting factor expression levels (FELs) to evaluate the modulation of the bleeding phenotype, aiming to offer consistent protection against breakthrough bleeding events. The link between FELs and bleeding risk in people with haemophili...

Descripción completa

Detalles Bibliográficos
Autores principales: Burke, Tom, Shaikh, Anum, Ali, Talaha M., Li, Nanxin, Konkle, Barbara A., Noone, Declan, O'Mahony, Brian, Pipe, Steven, O'Hara, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099781/
https://www.ncbi.nlm.nih.gov/pubmed/36331904
http://dx.doi.org/10.1111/hae.14675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099781/
https://www.ncbi.nlm.nih.gov/pubmed/36331904
http://dx.doi.org/10.1111/hae.14675

Ejemplares similares